Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients

Table 1 Characteristics of the study group (n = 160)

Parameter		n	Percentage (%)
Age (yr)	< 60	40	25.0
	≥ 60	120	75.0
Sex	Female	64	40.0
	Male	96	60.0
Location	Right-side	20	12.5
	Transverse	14	8.75
	Left-side	15	9.375
	Sigmoid	29	18.125
	Rectum	82	51.25
Tumour growth	Expanding	133	83.125
	Infiltrate	27	16.875
Tumour size	< 2.5 cm	27	16.875
	2.5-5.0 cm	106	66.25
	5.0 cm	27	16.875
TNM stage	1	42	26.25
	2	31	19.375
	3	69	43.125
	4	18	11.25
Grade of malignancy	2	148	92.5
	3	12	7.5
pT stage	1-2	65	40.625
	3-4	95	59.375
Venous invasion	Absent	113	70.625
	Present	46	28.75
Lymphatic invasion	Absent	121	75.625
	Present	38	23.75
Lymph-node metastasis	Absent	81	50.625
	Present	79	49.375
Distant metastasis	Absent	143	89.375
	Present	17	10.625
Tumour deposits	Absent	133	83.125
	Present	27	16.875
CEA levels (ng/mL)	< 3.5	124	77.5
	> 3.5	36	22.5
CA19-9 levels (U/mL)	< 27	150	93.75
	> 27	10	6.25
Monocyte count	Low group	152	95.0
	High group	8	5.0
MLR	Low group	112	70.0
	High group	48	30.0
PLT-NLR status	Score 0	46	28.75
	Score 1	82	51.25
	Score 2	32	20.0
NLR-PLR status	Score 0	16	10.0
	Score 1	21	13.125
	Score 2	123	76.875

TNM stage: Tumour-Node-Metastasis; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9; MLR: Monocyte-to-lymphocyte ratio; PLT-NLR status: Platelet and neutrophil-to-lymphocyte ratio; NLR-PLR status: Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.